Unexpectedly, mTORC1 inhibition with rapamycin actually promoted TFEB phosphorylation in TSC2 KO cells and xenografts, restored TFEB cytosolic localization and potently inhibited TSC2 KO tumor xenograft growth. Here, TSC2 is linked to neoplasm.